BIOTECanada welcomed the opportunity to comment on the pCPA’s proposed pCPA Temporary Access Process for select therapeutic products, recognizing the efforts towards process innovation, and encouraging the pCPA to think boldly about pathways to provide faster access for patients, sustainability for health system managers, and opportunities for Canada to improve its life science performance and international launch sequencing.
BIOTECanada